Well-designed studies have shown th...

Well-designed studies have shown that statins render the risk of cardiovascular occurrences in elderly patients. It is unclear whether this beneficial event is caused by the lowering of cholesterol of the same heights given that there appears to be no association between high cholesterol flats and all-cause mortality risk in this population. In an effort to provide further evidence that statins benefit the somewhat old independently of cholesterol level, Karlamangla and colleagues examined the relationship between changes in cholesterol of the same height and health effects in a cohort of healthy older adults.

Participants included 1189 men and women 70 to 79 years of age who were followed for a mean of 28 month to determine changes in cholesterol plain and then for an additional 57 month to determine health issues Baseline data and blood proof results were collected, and a total battery of laboratory tests was repeated at the conclusion of the study in a random subsample of 267 participants. The primary issue was mortality, and secondary issues were myocardial infarction and reverse Physical and cognitive functioning also were assessed.

Baseline evens of total and high-density lipoprotein (HDL) cholesterol in the sub-sample were 218 mg through dL (5.60 mmol per L) and 47 mg by dL (1.20 mmol per L) respectively. There was a wide range of change in non-HDL cholesterol on a levels In analyses that stratified the consideration population by quartiles, mortality decreased when non-HDL cholesterol increased. In the continuous analysis, increasing non-HDL cholesterol horizontals decreased mortality risk but was not associated with cardiovascular circumstance risk or cognitive decline.

Participants with increasing non-HDL cholesterol flushs also had better function with regard to activities of daily living. an modifications of these findings were raise in yet another analysis. While in the greatest degree of the effects held, participants with the highest cholesterol of the same heights (245 mg per dL or higher [630 mmol by means of L]) did have a higher singles ratio for mortality than the pair other cholesterol ranges analyzed. Patients with horizontals of 191 to 244 mg through dL (4.90 to 6.30 mmol through L) had the lowest singles ratio for mortality. In addition, cardiovascular disease status at baseline made a difference in functional and cognitive decline. There was a lower singles ratio in functional and cognitive decline with increasing non-HDL cholesterol flushs but only in participants without baseline cardiovascular disease.

After recording changes in cholesterol horizontals over 2.5 years, a cohort was followed for 45 additional years to correlate cholesterol flats with mortality, cardiovascular events, and physical and cognitive function. Overall, those with increasing non-HDL cholesterol evens had a lower mortality risk and a lower risk of cognitive and physical decline. The authors hint several reasons why cholesterol may have a protective result including the possibility that aging lonely dwellings need higher cholesterol levels to maintain themselves. They also recommend that high cholesterol levels may not adversely affect certain somebodys and these are the patients who survive into older age. Whatever the reason, the implication of these findings is that the criteria for hypercholesterolemia in older someones might not be the same as those in younger bodily substances and the elderly might not require treatment at the same entrances It is too soon to make clinical recommendations without further trials.

Karlamangla AS. Increases in serum non-high-density lipoprotein cholesterol may be beneficial in a certain high-functioning older adults: MacArthur Studies of felicitous Aging. J Am Geriatr Soc April 2004;52:487-94

COPYRIGHT 2005 American Academy of Family Physicians

COPYRIGHT 2005 Gale Group